[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352965-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352965-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pancreatic-tail-leiomyosarcoma-with-hepatic-metastases-diagnostic-and-therapeutic-challenges-a-case-report","Pancreatic Tail Leiomyosarcoma With Hepatic Metastases - Diagnostic and Therapeutic Challenges: A Case Report","","Primary pancreatic leiomyosarcoma (PLMS) is a rare malignant tumor (\u003C0.1% of pancreatic neoplasms) and often presents at an advanced stage with distant metastases or local invasion. Nonspecific symptoms such as abdominal discomfort, pain, or distension commonly cause delayed diagnosis. The report describes a 53-year-old woman with a 7.5 cm pancreatic tail mass and multiple liver metastases, encasement of splenic arteries, and no direct spleen or adrenal invasion. The case emphasizes diagnostic recognition and the lack of standardized therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pancreatic-tail-leiomyosarcoma-with-hepatic-metastases-diagnostic-and-therapeutic-challenges-a-case-report/352965/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pancreatic-tail-leiomyosarcoma-with-hepatic-metastases-diagnostic-and-therapeutic-challenges-a-case-report/352965.png","ImageObject",300,407,{"name":42,"@type":43},"Cart","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is pancreatic tail leiomyosarcoma difficult to diagnose?","Question",{"text":63,"@type":64},"It is extremely rare and its clinical symptoms are nonspecific (e.g., abdominal discomfort, pain, or distension), often leading to delayed diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What imaging findings characterized the reported case?",{"text":68,"@type":64},"Imaging showed a large pancreatic tail mass (~7.5 cm) with multiple hepatic lesions (at least 18 up to 2.5 cm), splenic artery encasement, invasion of the splenic vein, and no definite direct invasion of the spleen or adjacent adrenal gland.",{"name":70,"@type":61,"acceptedAnswer":71},"How is definitive diagnosis of PLMS typically established?",{"text":72,"@type":64},"Because imaging can mimic other tumors, histopathology and immunohistochemistry are essential, with tumors expressing smooth muscle markers (e.g., SMA, desmin, H-caldesmon) while lacking epithelial markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352965,1790543186,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Pancreatic Tail Leiomyosarcoma With Hepatic Metastases:  \nDiagnostic and Therapeutic Challenges: A Case Report  \nSomaya Al Kiswani 1, Nid’a Mubarak 1, Renad Abu Ruman 1, Muna Shahwan2, Rahaf Zorba2, Shaimaa Abu Laban2, Omar Sawafta2, and Abdullah Nofal 1  \nClinical Medicine Insights: Case Reports  \nVolume 19: 1–6 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/11795476261452331](DOI: 10.1177/11795476261452331)[ ](DOI: 10.1177/11795476261452331)[journals.sagepub.com/home/icr](journals.sagepub.com/home/icr)  \nAbstract  \nPrimary pancreatic leiomyosarcoma (PLMS) is a rare malignant tumor accounting for less than 0.1% of all pancreatic neoplasms and often presents at an advanced stage with distant metastases or local invasion. Clinical symptoms are nonspecific, including gastrointestinal discomfort, abdominal pain, or distension, which frequently leads to delayed diagnosis. We report a 53-year-old woman with persistent abdominal distension, bloating, and central discomfort, in whom imaging revealed a 7.5 cm mass in the pancreatic tail with multiple liver metastases, encasement of the splenic arteries, and no direct invasion of the spleen or adjacent adrenal gland; her family history was notable for hematological, breast, and pancreatic cancers. Due to its rarity, aggressive metastatic behavior, and lack of standardized therapy, PLMS presents significant diagnostic and treatment challenges. This case highlights the importance of recognizing pancreatic leiomyosarcoma as a distinct clinical entity and contributes to the limited literature guiding its management.  \nKeywords  \npancreatic leiomyosarcoma, pancreatic tail tumor, liver metastases, rare pancreatic neoplasm, smooth muscle sarcoma, soft tissue sarcoma, case report  \nReceived: 9 December 2025; accepted: 4 May 2026  \nIntroduction  \nLeiomyosarcoma of the pancreas is an extremely rare malignant neoplasm derived from smooth muscle cells, accounting for less than 0.1% of primary pancreatic malignancies. 1,2 Since its first description in 1951, approximately 100 cases have been reported in the literature.2,3 Patients typically present in the fifth to sixth decades of life with nonspecific symptoms such as abdominal pain, distension, or weight loss, often resulting in delayed diagnosis.  \nPancreatic leiomyosarcoma is characterized by aggressive behavior with a high propensity for local invasion and hematogenous spread, most commonly to the liver.2 Imaging findings are frequently nonspecific and may mimic pancreatic adenocarcinoma or other mesenchymal tumors, making histopathology and immunohistochemistry essential for definitive diagnosis. Tumors typically express smooth muscle markers such as SMA, desmin, and H-caldesmon while lacking epithelial markers.3,4  \nTreatment remains challenging due to the absence of standardized protocols. Surgical resection is preferred in  \nlocalized disease, whereas advanced cases are managed according to soft tissue sarcoma guidelines.5 This report highlights a metastatic tail-origin PLMS managed with sequential systemic therapies and emphasizes the importance of excluding metastatic uterine leiomyosarcoma in female patients.  \nCase Presentation  \nA 53-year-old woman with a history of hypertension, gout, and dyslipidemia, presented with intermittent abdominal pain in November 2023 which progressed to abdominal  \n1 Radiology Department, King Hussein Cancer Center, Amman, Jordan 2Department of Medicine, An Najah National University, Nablus, Palestine  \nCorresponding Author:  \nOmar Sawafta, Department of Medicine, An-Najah National University, Nablus P400, Palestine.  \n[Email: ojalal385@gmail.com](Email: ojalal385@gmail.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativ","cbCaiur1IrbLCNvb","https://ap.wps.com/l/cbCaiur1IrbLCNvb","pdf",970426,"English","# Abstract\n# Introduction\n# Case Presentation","[{\"question\":\"Why is pancreatic tail leiomyosarcoma difficult to diagnose?\",\"answer\":\"It is extremely rare and its clinical symptoms are nonspecific (e.g., abdominal discomfort, pain, or distension), often leading to delayed diagnosis.\"},{\"question\":\"What imaging findings characterized the reported case?\",\"answer\":\"Imaging showed a large pancreatic tail mass (~7.5 cm) with multiple hepatic lesions (at least 18 up to 2.5 cm), splenic artery encasement, invasion of the splenic vein, and no definite direct invasion of the spleen or adjacent adrenal gland.\"},{\"question\":\"How is definitive diagnosis of PLMS typically established?\",\"answer\":\"Because imaging can mimic other tumors, histopathology and immunohistochemistry are essential, with tumors expressing smooth muscle markers (e.g., SMA, desmin, H-caldesmon) while lacking epithelial markers.\"}]","Pancreatic Tail Leiomyosarcoma With Hepatic Metastases - Diagnostic and Therapeutic Challenges: A Case Report | PDF",1790102327,15,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/144ab698962342f89a501160065fc47e.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02533048a4efa53ac8908757904ff78c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50e54ef1307f9e27c9cc2d8a05556851.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/507b1830ef21a9483be49bb893f65801.webp",980,1385]